Risk and consequences of chemotherapy-induced neutropenic complications in patients receiving daily filgrastim: the importance of duration of prophylaxis
Crossref DOI link: https://doi.org/10.1186/1472-6963-14-189
Published Online: 2014-04-27
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Weycker, Derek
Barron, Rich
Edelsberg, John
Kartashov, Alex
Legg, Jason
Glass, Andrew G
Text and Data Mining valid from 2014-04-27
Article History
Received: 18 June 2013
Accepted: 8 April 2014
First Online: 27 April 2014